bimervax
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 8, 2023 (NCT06234956)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05981846 | Phase 2 | Sep 4, 2023 | Laboratorios Hipra, S.A. |
| NCT06234956 | Phase 2 | Jun 8, 2023 | Asphalion, Laboratorios Hipra, S.A., Veristat, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Laboratorios Hipra, S.A. | For profit | 2 | 2 | 1 | 2023 |
| Asphalion | For profit | 1 | 0 | 1 | 2023 |
| Veristat, Inc. | For profit | 1 | 0 | 1 | 2023 |
3 organizations
Page 1 / 1